Lai, S.-W.; Bamodu, O.A.; Chen, J.-H.; Wu, A.T.; Lee, W.-H.; Chao, T.-Y.; Yeh, C.-T.
Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer. Cells 2020, 9, 911.
https://doi.org/10.3390/cells9040911
AMA Style
Lai S-W, Bamodu OA, Chen J-H, Wu AT, Lee W-H, Chao T-Y, Yeh C-T.
Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer. Cells. 2020; 9(4):911.
https://doi.org/10.3390/cells9040911
Chicago/Turabian Style
Lai, Shiue-Wei, Oluwaseun Adebayo Bamodu, Jia-Hong Chen, Alexander TH Wu, Wei-Hwa Lee, Tsu-Yi Chao, and Chi-Tai Yeh.
2020. "Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer" Cells 9, no. 4: 911.
https://doi.org/10.3390/cells9040911
APA Style
Lai, S.-W., Bamodu, O. A., Chen, J.-H., Wu, A. T., Lee, W.-H., Chao, T.-Y., & Yeh, C.-T.
(2020). Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer. Cells, 9(4), 911.
https://doi.org/10.3390/cells9040911